Neurodevelopmental outcome at 36 months' corrected age of preterm infants in the multicenter indomethacin intraventricular hemorrhage prevention trial

Pediatrics

Volumn 98, Issue 4 PART 1, 1996, Pages 714-718

  Ment, Laura R ^a   Vohr, Betty ^b   Oh, William ^b   Scott, David T ^c   Allan, Walter C ^d   Westerveld, Michael ^a   Duncan, Charles C ^a   Ehrenkranz, Richard A ^a   Katz, Karol H ^a   Schneider, Karen C ^a   Makuch, Robert W ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d MAINE MEDICAL CENTER   (United States)

Author keywords

Indomethacin; Intraventricular hemorrhage; Neurodevelopmental outcome; Very low birth weight

Indexed keywords

INDOMETACIN; PLACEBO; SODIUM CHLORIDE;

ACADEMIC ACHIEVEMENT; ARTICLE; BRAIN HEMORRHAGE; CEREBRAL PALSY; CHILD DEVELOPMENT; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GESTATIONAL AGE; HEARING IMPAIRMENT; HUMAN; INTELLIGENCE QUOTIENT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTICENTER STUDY; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERY LOW BIRTH WEIGHT;

CEREBRAL HEMORRHAGE; CHI-SQUARE DISTRIBUTION; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CYCLOOXYGENASE INHIBITORS; HUMANS; INDOMETHACIN; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INTELLIGENCE TESTS; NEUROLOGIC EXAMINATION; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 10244224140     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Krishnamoorthy KS, Shannon DC, DeLong DR, Todres ID, Davis KR. Neurologic sequelae in the survivors of neonatal intraventricular hemorrhage. Pediatrics. 1979;64:233-237
2. Shinnar S, Molteni RA, Gammon K, D'Souza BJ, Altman J, Freeman JM. Intraventricular hemorrhage in the premature infant. N Engl J Med. 1982;306:1464-1468
3. McMenamin JB, Shackelford GD, Volpe JJ. Outcome of neonatal intraventricular hemorrhage with periventricular echodense lesions. Ann Neurol. 1984;15:285-290
4. Szymonowicz W, Yu VYH, Bajuk B, Astbury J. Neurodevelopmental outcome of periventricular haemorrhage and leukomalacia in infants 1250 g or less at birth. Early Hum Dev. 1986;14:1-7
5. Hanigan WC, Morgan AM, Anderson RJ, et al. Incidence and neurodevelopmental outcome of periventricular hemorrhage and hydrocephalus in a regional population of very low birth weight infants. Neurosurgery. 1991;29:701-706
6. Vohr BR, Garcia Coll C, Flanagan P, Oh W. Effects of intraventricular hemorrhage and socioeconomic status on perceptual, cognitive and neurologic status of low birth weight infants at 5 years of age. J Pediatr. 1992;121:280-285
7. Donn SM, Roloff DW, Goldstein GW. Prevention of intraventricular hemorrhage in preterm infants by phenobarbitone: a controlled trial. Lancet. 1981;2:215-217
8. Shankaran S, Cepeda EEG, Ilagan N, et al. Antenatal phenobarbital for the prevention of neonatal intracerebral hemorrhage. Am J Obstet Gynecol 1986;154:53-57
9. Benson JW, Drayton MR, Hayward C, et al. Multicentre trial of ethamsylate for prevention of periventricular hemorrhage in very low birth weight infants. Lancet. 1986;2:1294-1300
10. Speer ME, Blifeld C, Rudolph AJ, Chadda P, Holbein ME, Hittner HM. Intraventricular hemorrhage and vitamin E in the very low birth weight infant: evidence for efficacy of early intramuscular vitamin E administration. Pediatrics. 1984;74:1107-1112
11. Banstra ES, Montalvo BM, Goldberg RN, et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics. 1988;82:533-542
12. Wells JT, Ment LR. Prevention of intraventricular hemorrhage in preterm infants. Early Hum Dev. 1995;42:209-233
13. Ment LR, Duncan CC, Ehrenkranz RA, et al. Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr. 1988;112:948-955
14. Bada HS, Green RS, Pourcyrous M, et al. Indomethacin reduced the risks of severe intraventricular hemorrhage. J Pediatr. 1989;115:631-637
15. Hanigan W, Kennedy G, Roemisch F, Anderson R, Cusack T, Powers W. Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates. J Pediatr. 1988;112: 941-947
16. Ment LR, Duncan CC, Ehrenkranz RA, et al. Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr. 1985;107:937-943
17. Ment LR, Oh W, Ehrenkranz RA, et al. Low dose indomethacin therapy and prevention of intraventricular hemorrhage: a multicenter trial. Pediatrics. 1994;93:543-550
18. Edwards AD, Wyatt JS, Richardson C, et al. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet. 1990;335: 1491-1495
19. McCormick DC, Edwards AD, Brown GC, et al. Effect of indomethacin on cerebral oxidized cytochrome oxidase in preterm infants. Pediatr Res. 1993;33:603-608
20. Cowan F. Indomethacin, patent ductus arteriosus, and cerebral blood flow. J Pediatr. 1986;109:341-344
21. Van Bel F, Van de Bor M, Stijnen T, Baan J, Ruys JH. Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect. Pediatrics. 1989;84:802-807
22. Laudignon N, Chemtob S, Bard H, et al. Effect of indomethacin on cerebral blood flow velocity of premature newborns. Biol Neonate. 1988; 54:254-262
23. Mardoum R, Bejar R, Merritt TA, et al. Controlled study of the effects of indomethacin on cerebral blood flow velocities in newborn infants. J Pediatr. 1991;118:112-115
24. Pryds O, Greisen G, Johansen KH. Indomethacin and cerebral blood flow in premature infants treated for patent ductus arteriosus. Eur J Pediatr. 1988;147:315-316
25. Papile LS, Burstein J, Burstein R, et al. Incidence and evolution of the subependymal intraventricular hemorrhage: a study of infants with weights less than 1500 grams. J Pediatr. 1978;92:529-534
26. Allan WC, Philip AGS. Neonatal cerebral pathology diagnosed by ultrasound. Clin Perinatol. 1985;12:195-216
27. Constantine NA, Kraemer HC, Kendall-Tackett KA, et al. Use of physical and neurologic observations in assessment of gestational age in low birth weight infants. J Pediatr. 1987;110:921-928
28. Ballard JL, Novak KK, Driver M. A simplified score for assessment of fetal maturation of newly born infants. J Pediatr. 1979;95:769-774
29. Terman LM, Merrill MA. Stanford-Binet Intelligence Scale. Manual for the Third Revision. Chicago, IL: The Riverside Publishing Co; 1973
30. Dunn LM, Dunn LM. PPVT. Peabody Picture Vocabulary Test-revised. Form L. Circle Pines, MN: American Guidance Service; 1981
31. SAS Institute, Inc. SAS Stat Users Guide. Release 6.03, 4th ed. Cary, NC: SAS Institute, Inc; 1989: vols 1 and 2
32. Leffler CW, Busija DW, Fletcher AM, Beasley DG, Hessler JR, Green RS. Effects of indomethacin upon cerebral hemodynamics of newborn pigs. Pediatr Res. 1985;19:1160-1164
33. Chemtob S, Beharry K, Barna T, Varma DR, Aranda JV. Differences in the effects in the newborn piglet of various nonsteroidal anti-inflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Pediatr Res. 1991;30:106-111
34. Dahlgren N, Nilsson B, Sakabe T, et al. The effect of indomethacin on cerebral blood flow and oxygen consumption in the rat at normal and increased carbon dioxide tensions. Acta Physiol Scand. 1982;111:475-485
35. Leffler CW, Busija DW, Beasley DG, et al. Effects of indomethacin on cardiac outcome distribution in normal and asphyxiated piglets. Prostaglandins. 1986;31:183-190
36. Northover BJ. Indomethacin: a calcium antagonist. Gen Pharmacol. 1983; 8:293-296
37. Ment LR, Stewart WB, Scott DT, Duncan CC. Beagle puppy model of intraventricular hemorrhage: randomized indomethacin prevention trial. Neurology. 1983;33:179-184
38. Volpe JJ. Brain injury caused by intraventricular hemorrhage: is indomethacin the silver bullet for prevention? Pediatrics. 1994;93:673-677
39. Reynolds EOR, Meek J. Prevention of periventricular hemorrhage. Pediatrics. 1994;93:677-679
40. Annibale DJ. Evaluating the strength of medical literature: indomethacin in the neonatal intensive care unit. Neonatal Intensive Care. 1994; (May/June):22-29
41. Fowlie PW. Prophylactic indomethacin: systematic review and metaanalysis. Arch Dis Child. 1996;74:F81-F87
42. Setzer EM, Duenas ML, Rodriquez I, et al. Prophylactic indomethacin for prevention of intraventricuiar hemorrhage (IVH): neurodevelopmental follow-up. Pediatr Res. 1987;21:391A. Abstract
43. Ment LR, Ehrenkranz RA, Allan WC, Oh W. Antenatal exposure to steroids and the additional prophylaxis effect of indomethacin to prevent IVH. Pediatrics. 1996;97:601. Letter
44. Mahony L, Garner V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth weight infants. N Engl J Med. 1982;306:506-510
45. Gersony WM, Peckham GJ, Ellison RC, et al. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr. 1983;102:895-906
46. Weiss H, Cooper B, Brook M, Schlueter M, Clyman R. Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin. J Pediatr. 1995;127:466-471